VANCE DOLLY 4
4 · RIGEL PHARMACEUTICALS INC · Filed Jan 26, 2022
Insider Transaction Report
Form 4
VANCE DOLLY
SVP, Gen. Counsel, Corp. Sec.
Transactions
- Award
Common Stock
2022-01-24+50,000→ 60,260 total - Award
Stock Option (Right to Buy)
2022-01-24+100,000→ 100,000 totalExercise: $2.42Exp: 2032-01-24→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from February 1, 2022, with the first annual vest occurring on February 1, 2023.
- [F2]Includes 9,685 shares acquired under the Issuer's stock purchase plan.
- [F3]The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2022, subject to the reporting person's continuous service to the issuer through each such period.